Early introduction of tolvaptan after cardiac surgery: a renal sparing strategy in the light of the renal resistive index measured by ultrasound

BACKGROUND: Renal failure is a serious complication after cardiac surgery, which can be caused by long-term intravenous (IV) loop diuretic use. Tolvaptan is an oral selective vasopressin-2 receptor antagonist used in patients irresponsive to loop diuretics. We investigated their renal perfusion chan...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cardiothorac Surg
Hlavní autoři: Kato, Tomoko S., Ono, Shunya, Kajimoto, Kan, Kuwaki, Kenji, Yamamoto, Taira, Amano, Atsushi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631092/
https://ncbi.nlm.nih.gov/pubmed/26525900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-015-0372-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky